GGrantIndex
← Leaderboards

Stephanie Karst

University Of Florida

$15,010,959
Attributed
$15,010,959
Total exposure
15
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,010,959 · 15

By mechanism

R01$11,064,427 · 5
R56$1,442,443 · 3
P20$1,198,225 · 5
T32$904,820 · 1
R21$401,044 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Top investigators on “Norovirus

Research focus

NorovirusInfectionVirusIntestinesGastroenteritisCellsDiarrheaViralPathogenesisIn VivoInsightChildhoodImmunityImmune ResponseIn VitroPreventB-LymphocytesResponseImmuneEnteralMolecularBiological ModelsCell Culture SystemVaccines

Grant awards (39)

Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea$603,957
R01 · FY2025 · AI · contact PI
Basic Microbiology and Infectious Disease$221,375
T32 · FY2025 · AI · contact PI
Regulation of enteric norovirus infection by host-derived and microbiota-transformed bile acids$642,669
R56 · FY2024 · AI · contact PI
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea$603,957
R01 · FY2024 · AI · contact PI
Basic Microbiology and Infectious Disease$232,649
T32 · FY2024 · AI · contact PI
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea$603,957
R01 · FY2023 · AI · contact PI
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids$537,428
R01 · FY2023 · AI · contact PI
Basic Microbiology and Infectious Disease$220,534
T32 · FY2023 · AI · contact PI
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea$603,957
R01 · FY2022 · AI · contact PI
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids$537,428
R01 · FY2022 · AI · contact PI
Basic Microbiology and Infectious Disease$230,262
T32 · FY2022 · AI · contact PI
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea$603,957
R01 · FY2021 · AI · contact PI
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids$537,428
R01 · FY2021 · AI · contact PI
Identification of Host and Viral Determinants of Human Norovirus B cell Infection$477,833
R01 · FY2021 · AI · contact PI
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids$537,187
R01 · FY2020 · AI · contact PI
Identification of Host and Viral Determinants of Human Norovirus B cell Infection$477,833
R01 · FY2020 · AI · contact PI
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids$562,595
R01 · FY2019 · AI · contact PI
Identification of Host and Viral Determinants of Human Norovirus B cell Infection$477,833
R01 · FY2019 · AI · contact PI
Role of Intestinal Bacteria in Human Norovirus Infection$368,455
R01 · FY2019 · AI · contact PI
Identification of Host and Viral Determinants of Human Norovirus B cell Infection$477,833
R01 · FY2018 · AI · contact PI
Role of Intestinal Bacteria in Human Norovirus Infection$368,767
R01 · FY2018 · AI · contact PI
Role of Intestinal Bacteria in Human Norovirus Infection$369,063
R01 · FY2017 · AI · contact PI
Identification of Host and Viral Determinants of Human Norovirus B cell Infection$358,654
R01 · FY2017 · AI · contact PI
Identification of Host and Viral Determinants of Human Norovirus B cell Infection$470,149
R56 · FY2016 · AI · contact PI
Role of Intestinal Bacteria in Human Norovirus Infection$369,346
R01 · FY2016 · AI · contact PI
Role of Intestinal Bacteria in Human Norovirus Infection$369,615
R01 · FY2015 · AI · contact PI
Lack of protective immunity to murine norovirus infection$300,612
R01 · FY2013 · AI · contact PI
Lack of protective immunity to murine norovirus infection$320,652
R01 · FY2012 · AI · contact PI
Lack of protective immunity to murine norovirus infection$321,392
R01 · FY2011 · AI · contact PI
Persistent norovirus infection impairs protective immunity$181,294
R21 · FY2011 · AI · contact PI
Persistent norovirus infection impairs protective immunity$219,750
R21 · FY2010 · AI · contact PI
LSUHSC COBRE: NOROVIRUS IMMUNITY AND PATHOGENESIS$209,863
P20 · FY2010 · RR · contact PI
Lack of protective immunity to murine norovirus infection$191,193
R01 · FY2010 · AI · contact PI
Lack of protective immunity to murine norovirus infection$83,495
R01 · FY2010 · AI · contact PI
Lack of protective immunity to murine norovirus infection$329,625
R56 · FY2009 · AI · contact PI
LSUHSC COBRE: NOROVIRUS IMMUNITY AND PATHOGENESIS$211,337
P20 · FY2009 · RR · contact PI
LSUHSC COBRE: REPLICATION OF MURINE NOROVIRUS 1, MNV-1$296,166
P20 · FY2008 · RR · contact PI
LSUHSC COBRE: REPLICATION OF MURINE NOROVIRUS 1, MNV-1$240,271
P20 · FY2007 · RR · contact PI
LSUHSC COBRE: REPLICATION OF MURINE NOROVIRUS 1, MNV-1$240,588
P20 · FY2006 · RR · contact PI